Portfolio Lab

HCA Healthcare, Inc.

  • Stock
  • Ticker HCA
  • ISIN US40412C1018
  • NYSE

Health care · Health care services · USA

$475.57 +3.31%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of HCA Healthcare, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

HCAGlobal equities (VT)

$10,000 grew to $70,619. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −54.7% in 03/2020, measured from the peak in 02/2020. It took 9 months to get back to the old peak.

1-year return
+0.5%
5-year return p.a.
+15.7%
10-year return p.a.
+21.6%
Volatility p.a.
33.5%
Largest decline
−54.7%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue18,28518,32118,60519,16119,51319,10920,23019,849
Net income1,4381,6101,6531,6431,8781,6201,6991,579
Earnings per share5.636.456.836.968.107.157.627.27
Balance sheet
Total assets59,51359,79859,53659,74760,72061,45063,25063,452
Liabilities58,95860,23660,77461,90663,49164,42866,45968,051
Equity-2,499-3,519-4,394-5,335-6,027-6,303-6,642-8,077
Cash1,9331,0609399971,0409401,013908
Long-term debt38,33341,05739,37938,40141,60339,49143,45442,400
Cash flow
Operating cash flow2,5591,6514,2104,4162,3592,0142,3354,461
Capital expenditure-1,285-991-1,176-1,288-1,489-1,119-1,231-1,357
Free cash flow1,2746603,0343,1288708951,1043,104

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +57.6%, weakest 2022 at −5.6%. 8 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
29 Oct 2026$7.27
28 Jul 2026$7.62
29 Apr 2026$7.15
10 Feb 2026$8.10
30 Oct 2025$6.96
4 Aug 2025$6.83
1 May 2025$6.45
14 Feb 2025$5.63
31 Oct 2024$4.88
29 Jul 2024$5.53
2 May 2024$5.93
16 Feb 2024$5.90

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€90bn
Market cap in trading currency
$99.3bn
Enterprise value
$143bn
P/E
15.8
P/S
1.26
P/B
–
EV/Sales
1.82
EV/EBITDA
9.0
Earnings yield
6.3%
FCF yield
6.0%

Results (last four quarters)

Revenue
$78.7bn
Gross profit
–
EBITDA
$15.9bn
Net income
$6.78bn
Earnings per share
$30.14
Revenue per share
$376.75
Revenue growth
+3.6%
Earnings growth
−3.9%

Profitability

Gross margin
–
Operating margin
15.5%
Net margin
8.6%
Return on equity
–
Return on assets
10.7%

Balance sheet and cash flow

Cash
$908m
Cash per share
$4.35
Financial debt
$44.8bn
Debt/equity %
–
Current ratio
0.82
Book value per share
−$38.67
Operating cash flow
$11.2bn
Free cash flow
$5.97bn

Dividend

Dividend yield
0.64%
Dividend (12 months)
$3.06
Yield (12 months)
0.64%
Payout ratio
10%
Ex-dividend date
16 Sep 2026

Shares and trading

Shares outstanding
209m
Volume
1.58m
Avg. volume 3 months
1.37m
Relative volume
1.2

Price and technicals

Price
$475.57
1 day
+3.3%
52-week high
$545.13
52-week low
$361.32
Distance to 52-week high
−12.8%
Distance to 52-week low
+31.6%
Distance to 50-day line
+3.4%
Distance to 200-day line
+6.9%
RSI (14)
49
Volatility 1M
50.4%

Performance

1 week
−4.7%
1 month
+1.8%
3 months
+10.8%
6 months
+20.7%
YTD
+1.9%
1 year
−1.1%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has HCA performed since 11/2016?

$10,000 grew to $70,619 by 20 Nov 2026, which is +21.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is HCA?

Volatility was 33.5% per year, measured on monthly returns. The largest decline from a peak was −54.7%, with the low in 03/2020.

How does HCA compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, HCA returned +21.6% at 33.5%. The correlation of monthly returns was 0.63; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

HCA Healthcare, Inc. (HCA): Return and risk | Portfolio Lab